These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 27053860)

  • 1. Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease?
    Burr NE; Hull MA; Subramanian V
    World J Gastroenterol; 2016 Apr; 22(13):3679-86. PubMed ID: 27053860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.
    Qiu X; Ma J; Wang K; Zhang H
    Oncotarget; 2017 Jan; 8(1):1031-1045. PubMed ID: 27906680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesalamine protects against colorectal cancer in inflammatory bowel disease.
    Tang J; Sharif O; Pai C; Silverman AL
    Dig Dis Sci; 2010 Jun; 55(6):1696-703. PubMed ID: 19705280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aspirin and NSAIDs on risk and survival from colorectal cancer.
    Din FV; Theodoratou E; Farrington SM; Tenesa A; Barnetson RA; Cetnarskyj R; Stark L; Porteous ME; Campbell H; Dunlop MG
    Gut; 2010 Dec; 59(12):1670-9. PubMed ID: 20844293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
    Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
    Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-aspirin non-steroidal anti-inflammatory drugs in prevention of colorectal cancer in people aged 40 or older: A systematic review and meta-analysis.
    Tomić T; Domínguez-López S; Barrios-Rodríguez R
    Cancer Epidemiol; 2019 Feb; 58():52-62. PubMed ID: 30472477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use.
    Samadder NJ; Mukherjee B; Huang SC; Ahn J; Rennert HS; Greenson JK; Rennert G; Gruber SB
    Cancer; 2011 Apr; 117(8):1640-8. PubMed ID: 21472711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal anti-inflammatory drugs but not aspirin are associated with a lower risk of post-colonoscopy colorectal cancer.
    Cheung KS; Chen L; Chan EW; Seto WK; Wong ICK; Leung WK
    Aliment Pharmacol Ther; 2020 May; 51(9):899-908. PubMed ID: 32201976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin for the prevention of colorectal cancer.
    Garcia-Albeniz X; Chan AT
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):461-72. PubMed ID: 22122763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs.
    Chan AT; Ogino S; Giovannucci EL; Fuchs CS
    Gastroenterology; 2011 Mar; 140(3):799-808, quiz e11. PubMed ID: 21115010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
    Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L
    J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin as a chemoprevention agent for colorectal cancer.
    Lee CS; McNamara D; O'Morain CA
    Curr Drug Metab; 2012 Nov; 13(9):1313-22. PubMed ID: 22493984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-aspirin non-steroidal anti-inflammatory drugs in colorectal cancer: a review of clinical studies.
    Zaman FY; Orchard SG; Haydon A; Zalcberg JR
    Br J Cancer; 2022 Nov; 127(10):1735-1743. PubMed ID: 35764787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow.
    Ryan BM; Russel MG; Langholz E; Stockbrugger RW
    Am J Gastroenterol; 2003 Aug; 98(8):1682-7. PubMed ID: 12907319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis.
    González-Pérez A; García Rodríguez LA; López-Ridaura R
    BMC Cancer; 2003 Oct; 3():28. PubMed ID: 14588079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer.
    Peleg II; Maibach HT; Brown SH; Wilcox CM
    Arch Intern Med; 1994 Feb; 154(4):394-9. PubMed ID: 8117171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review: interactions between aspirin, and other nonsteroidal anti-inflammatory drugs, and polymorphisms in relation to colorectal cancer.
    Andersen V; Vogel U
    Aliment Pharmacol Ther; 2014 Jul; 40(2):147-59. PubMed ID: 24889212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylsalicylic Acid and its Potential for Chemoprevention of Colorectal Carcinoma.
    Podhorec J; Hrstka R; Bílek O; Tuček Š; Navrátil J; Michalová E; Vojtěšek B
    Klin Onkol; 2018; 31(Suppl 2):77-81. PubMed ID: 31023028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease.
    Chan EP; Lichtenstein GR
    Gastroenterol Clin North Am; 2006 Sep; 35(3):675-712. PubMed ID: 16952746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.